DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms.

MLA

Ke, Chiao-Hsu, et al. “DR-70 (Fibrinogen-Fibrin Degradation Products) as a Prognostic Biomarker in Dogs with Neoplasms.” The Veterinary Quarterly, vol. 44, no. 1, Dec. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1080/01652176.2024.2380049.

APA

Ke, C.-H., Lin, C.-S., Sio, K.-M., Wu, C.-H., Xia, Y.-Y., Lee, J.-J., Hu, C.-H., Liu, C.-C., Liaw, B.-S., Cheng, C.-L., Lin, K.-H., & Wang, Y.-S. (2024). DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms. The Veterinary Quarterly, 44(1), 1–10. https://doi.org/10.1080/01652176.2024.2380049

Chicago

Ke, Chiao-Hsu, Chen-Si Lin, Ka-Mei Sio, Chun-Hung Wu, Yuan-Yuan Xia, Jih-Jong Lee, Chin-Hao Hu, et al. 2024. “DR-70 (Fibrinogen-Fibrin Degradation Products) as a Prognostic Biomarker in Dogs with Neoplasms.” The Veterinary Quarterly 44 (1): 1–10. doi:10.1080/01652176.2024.2380049.